NuuVim Telehealth & Prescription Medication Disclosures

These Telehealth & Prescription Medication Disclosures (“Disclosures”) apply to services made available through or in connection with NuuVim LLC (“NuuVim,” “we,” “us,” or “our”), including services accessed through our website, intake flow, patient communications, and related online services.

Please read these Disclosures carefully. These Disclosures are intended to help you understand how NuuVim’s telehealth-supported weight management services work, the roles of the parties involved, the limitations and risks of telehealth, and important information about prescription and compounded medications.

These Disclosures supplement, and do not replace, any applicable Terms of Use, Privacy Policy, Notice of Privacy Practices, telehealth informed consent, financial policy, subscription policy, pharmacy information, medication guide, or other disclosures provided by NuuVim, Bask Health Inc. (“Bask”), Beluga Health, P.A. (“Beluga”), any affiliated medical group, any treating healthcare practitioner, or any dispensing pharmacy.

If there is a conflict between these Disclosures and the clinical consent or medical information provided by your treating healthcare practitioner, the clinical consent and practitioner-provided medical information control with respect to your medical care.

1. Emergency Medical Notice

2. Who Provides Medical Care

NuuVim is not a medical group, pharmacy, or healthcare practitioner. NuuVim does not practice medicine, diagnose medical conditions, prescribe medications, dispense medications, or control the clinical judgment of healthcare practitioners.

Medical care, including any diagnosis, treatment recommendation, prescription decision, follow-up care, and medication management, is provided by independent licensed healthcare practitioners through Beluga Health, P.A. and/or other applicable affiliated professional entities or licensed medical groups made available through Bask.

Bask provides or supports the technology platform used to collect information, facilitate telehealth encounters, and support communication between patients and healthcare practitioners.

A licensed healthcare practitioner will be responsible for determining whether telehealth is appropriate for you, whether a practitioner-patient relationship may be established, whether treatment is medically appropriate, and whether any prescription should be issued.

3. Services Available Through NuuVim

NuuVim offers access to telehealth-supported medical weight management services for eligible patients. Services may include online intake, health questionnaires, asynchronous telehealth review, practitioner-patient messaging, treatment recommendations, prescription support where medically appropriate, access to medication fulfillment through licensed pharmacies, and related patient support.

Services may include evaluation for prescription weight management medications, including compounded GLP-1 or GLP-1/GIP medications, where permitted by law and where determined medically appropriate by a licensed healthcare practitioner.

NuuVim does not guarantee that you will be eligible for treatment. NuuVim does not guarantee that you will receive a prescription, a particular medication, a particular dose, a refill, a continued prescription, or any specific treatment outcome.

4. States Where Services Are Available

NuuVim services are available only in states where the applicable healthcare practitioners, medical groups, pharmacies, and platform partners are legally authorized to provide the relevant services.

Services are currently available in the following states:

Services are available in all 50 US states through affiliated medical providers and pharmacy partners operating in accordance with applicable state licensure requirements. Please note that certain medications, formulations, or fulfillment options may vary depending on state-specific pharmacy regulations and dispensing restrictions.

Availability may change based on changes in law, practitioner licensure, pharmacy availability, operational requirements, medication availability, or other factors.

You must be physically located in a state where services are available at the time you receive telehealth services. Your healthcare practitioner may ask you to confirm your identity, location, and other eligibility information before providing care.

5. Telehealth and Asynchronous Telehealth

Telehealth is the delivery of healthcare services using electronic communications technologies when the patient and healthcare practitioner are not in the same physical location.

Telehealth may include asynchronous, store-and-forward communications. Asynchronous telehealth means that you and the healthcare practitioner may not communicate at the same time. For example, you may complete an online questionnaire, submit health information, upload photos or documents if requested, or send secure messages, and a healthcare practitioner may review that information later.

Telehealth may also include secure messaging, SMS/MMS communications, email communications, telephone calls, video visits, or other communication methods, depending on the services available and the healthcare practitioner’s judgment.

A healthcare practitioner may determine that asynchronous telehealth is not appropriate for your condition or circumstances. If that happens, you may be directed to seek in-person care, urgent care, emergency care, primary care, specialist care, laboratory testing, or another form of evaluation.

6. Consent to Telehealth

By using NuuVim’s services, continuing through the intake flow, or accepting any applicable telehealth consent presented to you, you acknowledge and understand that:

1. You are requesting telehealth services from licensed healthcare practitioners who may be located remotely from you.
2. Your healthcare practitioner may not be physically present with you.
3. Your healthcare practitioner may rely on information that you provide through an online questionnaire, intake form, secure message, SMS/MMS, email, phone call, video visit, laboratory results, pharmacy records, prescription history, photographs, or other information made available through the telehealth platform.
4. Your healthcare practitioner may not have access to your complete medical records unless you provide them or authorize access.
5. Telehealth has limitations and may not be appropriate for every patient, condition, or treatment request.
6. You have the right to ask questions about telehealth and, where required by law, to withdraw your consent to telehealth.
7. If you do not want to receive care through telehealth, you may seek in-person care from a healthcare practitioner of your choice.

7. Patient Responsibilities

You are responsible for providing accurate, complete, and current information. This includes information about your identity, age, location, medical history, allergies, medications, supplements, prior diagnoses, pregnancy or breastfeeding status, laboratory results, prior adverse reactions, and any other information requested by your healthcare practitioner.

You agree that:

1. You will not provide false, incomplete, or misleading information.
2. You will promptly update your healthcare practitioner if your health information changes.
3. You will not use another person’s identity or account.
4. You will not seek medication for someone else through your account.
5. You will be physically located in a state where services are available at the time you receive telehealth services.
6. You will follow instructions provided by your healthcare practitioner and dispensing pharmacy.
7. You will contact your healthcare practitioner if you have questions about your medication, dose, side effects, storage, administration, or treatment plan.
8. You will seek emergency care when appropriate.

Failure to provide accurate and complete information may increase the risk of inappropriate treatment, adverse drug interactions, allergic reactions, delayed diagnosis, or other negative health outcomes.

8. No Guarantee of Treatment, Prescription, Weight Loss, or Results

Completion of an online intake form, payment, account creation, or submission of health information does not guarantee that a healthcare practitioner will determine that treatment is appropriate.

A prescription will be issued only if a licensed healthcare practitioner determines, in their independent clinical judgment, that the prescription is medically appropriate and legally permissible.

NuuVim does not guarantee:

1. That you will be approved for treatment.
2. That you will receive a prescription.
3. That you will receive any specific medication.
4. That you will receive any specific dose.
5. That you will receive a refill.
6. That your treatment will continue indefinitely.
7. That a particular pharmacy will dispense your medication.
8. That medication will be available at any particular time.
9. That you will experience weight loss.
10. That you will achieve any specific health, wellness, or appearance-related result.

Individual results vary. Weight management treatment may require diet, exercise, behavioral changes, medical monitoring, laboratory testing, and ongoing clinical evaluation. Medication alone may not produce the results you expect.

9. Valid Prescription Policy

Prescription medications are available only pursuant to a valid prescription issued by a licensed healthcare practitioner who is authorized to prescribe in accordance with applicable law.

NuuVim does not sell prescription medication without a valid prescription. NuuVim does not issue prescriptions. NuuVim does not dispense prescription medications.

A prescription will not be issued solely because you completed an online questionnaire or paid for a service. Your healthcare practitioner must review your information and determine that a prescription is medically appropriate and legally permissible.

Your healthcare practitioner may deny treatment, require additional information, request laboratory testing, require an in-person evaluation, refer you to another provider, or direct you to seek urgent or emergency care.

10. Practitioner-Patient Relationship

A practitioner-patient relationship is established only when permitted by applicable law and when a licensed healthcare practitioner determines that sufficient information exists to evaluate and treat you through telehealth.

Depending on your state and circumstances, the practitioner may need to verify your identity and location, obtain your medical history, review your health information, assess whether telehealth is appropriate, and determine whether additional information or an in-person visit is required.

The existence of a NuuVim account or completion of an intake form does not, by itself, create a practitioner-patient relationship with NuuVim, Bask, Beluga, or any healthcare practitioner.

11. Limitations and Risks of Telehealth

Telehealth may offer convenience and expanded access to care, but it also has risks and limitations. These may include:

1. Delays in evaluation, diagnosis, treatment, or communication.
2. Incomplete, inaccurate, or outdated information.
3. Lack of access to your complete medical records.
4. Inability to perform a hands-on physical examination.
5. Technical failures, service interruptions, or poor data quality.
6. Unauthorized access to personal information despite security safeguards.
7. Miscommunication through electronic communications.
8. Limitations in assessing symptoms remotely.
9. Need for follow-up care, laboratory testing, specialist evaluation, or in-person care.
10. Risk that your condition may not improve or may worsen.

Your healthcare practitioner may determine that telehealth is not appropriate for you or that your condition requires a different form of care.

12. Weight Management Treatment

Weight management treatment may include lifestyle counseling, dietary changes, physical activity recommendations, behavioral support, laboratory testing, prescription medication when medically appropriate, and ongoing medical monitoring.

Prescription weight management medications may not be appropriate for everyone. Your healthcare practitioner will consider the information you provide and may consider factors such as your body mass index, medical history, current medications, allergies, pregnancy or breastfeeding status, prior treatment history, contraindications, and other clinical factors.

You should tell your healthcare practitioner if you have or have had any of the following, or if any of the following apply to you:

1. Pregnancy, plans to become pregnant, or breastfeeding.
2. Personal or family history of medullary thyroid carcinoma.
3. Multiple endocrine neoplasia syndrome type 2.
4. Pancreatitis.
5. Gallbladder disease.
6. Severe gastrointestinal disease.
7. Kidney disease.
8. Diabetes or use of insulin or sulfonylureas.
9. Eating disorders.
10. Prior allergic reactions to weight management medications.
11. Any other serious medical condition.
12. Any current prescription medications, over-the-counter medications, supplements, or herbal products.

This list is not complete. Your healthcare practitioner may ask additional questions to determine whether treatment is appropriate.

13. Medication Safety Information

Prescription medications may have risks, side effects, contraindications, warnings, and drug interactions. You should carefully review all medication information provided by your healthcare practitioner, pharmacy, medication packaging, and any medication guide or safety information made available to you.

Possible side effects of GLP-1 or GLP-1/GIP medications may include nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, dehydration, injection-site reactions, hypoglycemia when used with certain diabetes medications, gallbladder problems, pancreatitis, kidney problems, allergic reactions, and other side effects.

Some side effects can be serious. Contact your healthcare practitioner promptly if you experience concerning symptoms. Seek emergency medical care if you experience symptoms that may indicate a medical emergency, including severe allergic reaction, severe abdominal pain, severe dehydration, chest pain, trouble breathing, fainting, or other severe or rapidly worsening symptoms.

Medication safety information:

https://www.nuuvim.com/faq

14. Compounded Medication Disclosure

Some medications made available through NuuVim may be compounded medications, including compounded GLP-1 or GLP-1/GIP medications, when prescribed by a licensed healthcare practitioner and dispensed by a licensed pharmacy.

Compounded medications are prepared by a pharmacy or outsourcing facility for a specific patient or clinical need. Compounded medications are not the same as FDA-approved commercially available drugs.

Compounded medications are not FDA-approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Compounded medications may be appropriate only when a licensed healthcare practitioner determines that a patient’s medical needs cannot be met by an FDA-approved commercially available medication or when otherwise permitted by applicable law.

Compounded medications may differ from FDA-approved products in formulation, ingredients, concentration, dosage form, delivery method, packaging, storage requirements, administration instructions, and other characteristics.

You should use compounded medication only as prescribed and only after receiving instructions from your healthcare practitioner and dispensing pharmacy.

15. Compounded GLP-1 / GLP-1/GIP Medication Risks

Compounded GLP-1 or GLP-1/GIP medications may involve additional risks, including:

1. Dosing errors, especially if medication is supplied in a vial and requires measuring with a syringe.
2. Confusion regarding units, milligrams, milliliters, or injection volume.
3. Variation in concentration or formulation.
4. Improper storage or temperature exposure during shipping or after delivery.
5. Use of medication after its beyond-use date.
6. Quality concerns if medication is not obtained from a properly licensed pharmacy.
7. Risks related to active pharmaceutical ingredients or inactive ingredients.
8. Potential for side effects, adverse reactions, or lack of expected effect.
9. Potential medication shortages or changes in availability.
10. Potential changes in applicable law or regulatory policy affecting availability.

You should not use any injectable medication if it appears damaged, contaminated, discolored, improperly labeled, expired, previously opened, or if it arrived warm when refrigeration was required. Contact the dispensing pharmacy and your healthcare practitioner if you have concerns about your medication.

You should not change your dose, increase your dose, take extra medication, restart medication after a missed period, or combine medications unless directed by your healthcare practitioner.

16. Relationship to Brand-Name Medications

Compounded medications made available through NuuVim, if prescribed, are not FDA-approved brand-name medications.

NuuVim is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any manufacturer of FDA-approved GLP-1 or GLP-1/GIP medications.

Unless expressly stated otherwise, references to semaglutide, tirzepatide, GLP-1, GLP-1/GIP, or similar terms refer to the active ingredient or medication category and do not mean that you will receive Ozempic®, Wegovy®, Mounjaro®, Zepbound®, or any other brand-name medication.

Brand names are used only for identification and educational purposes where applicable. All trademarks belong to their respective owners.

17. Pharmacy Fulfillment

If your healthcare practitioner prescribes medication, the prescription may be sent to a licensed pharmacy for fulfillment. The dispensing pharmacy is responsible for dispensing the medication in accordance with applicable pharmacy laws and professional standards.

NuuVim does not compound or dispense medications.

Dispensing pharmacy information:

You may contact the dispensing pharmacy with questions about medication preparation, dispensing, shipping, storage, labeling, beyond-use date, administration supplies, or pharmacy-specific instructions.

Where permitted and operationally available, you may request that your prescription be sent to a pharmacy of your choice. Your requested pharmacy must be legally able and willing to dispense the prescribed medication.

18. Shipping, Storage, and Delivery

If medication is shipped to you, shipping may be handled by the dispensing pharmacy or its shipping partners. Shipping times are estimates and are not guaranteed.

You are responsible for promptly retrieving shipped medication, inspecting the package, reviewing the label and instructions, and storing the medication as directed.

Some injectable medications may require refrigeration or other special storage conditions. Follow the pharmacy’s storage instructions carefully.

Contact the pharmacy and your healthcare practitioner if:

1. Your package appears damaged.
2. Your medication appears warm when cold shipping was required.
3. The medication appears contaminated, cloudy, discolored, or otherwise unusual.
4. The label contains incorrect information.
5. The supplies are missing or damaged.
6. You are unsure how to measure or administer your dose.
7. You missed doses or stored the medication incorrectly.

Do not use medication if you are unsure whether it is safe to use.

19. Laboratory Testing and Third-Party Services

Your healthcare practitioner may require or recommend laboratory testing or other diagnostic services before or during treatment. Laboratory testing may be provided by third-party laboratories or other service providers.

Laboratory tests may have limitations and may produce false positive, false negative, delayed, incomplete, or inconclusive results. Laboratory results must be interpreted by a qualified healthcare practitioner in light of your overall health information.

Third-party laboratories, pharmacies, shipping companies, payment processors, technology providers, and other service providers may have their own policies, terms, notices, and billing practices.

Patients in certain states may have rights to request itemized laboratory pricing or billing information. See the state-specific disclosures section below.

20. Financial Responsibility, Subscriptions, Refunds, and Cancellation

You are responsible for reviewing all pricing, subscription, billing, cancellation, and refund terms before purchasing or continuing services.

Payment does not guarantee approval for treatment, issuance of a prescription, medication availability, medication shipment, treatment success, or any specific outcome.

If your healthcare practitioner determines that treatment is not medically appropriate, your purchase, refund, cancellation, or credit rights will be handled according to the applicable NuuVim financial policy, subscription policy, refund policy, or checkout terms.

21. Insurance

Unless expressly stated otherwise, NuuVim services are cash-pay and may not be covered by insurance. NuuVim does not guarantee insurance coverage, reimbursement, or eligibility for health plan benefits.

If insurance billing is available for any service, you are responsible for understanding your benefits, coverage limitations, deductibles, copayments, coinsurance, out-of-network charges, and any amounts not paid by your health plan.

22. Electronic Communications, SMS, Email, and Phone Calls

By providing your contact information and using the services, you authorize NuuVim, Bask, Beluga, healthcare practitioners, pharmacies, laboratories, and service providers to contact you by phone, email, SMS, MMS, patient portal message, or other electronic means regarding your account, intake, treatment, prescriptions, medication shipments, payment, customer support, and related services.

Electronic communications may include personal information or health-related information. Although safeguards may be used, electronic communications may involve risks, including unauthorized access, misdirected messages, device access by others, carrier or internet service issues, or delays.

Standard message and data rates may apply. Message frequency may vary.

Transactional or healthcare-related communications may be necessary to provide services. Marketing communications, where used, will be handled in accordance with applicable law and any consent requirements.

You may opt out of certain SMS or marketing communications by following the instructions provided in the message or contacting us at admin@belugahealth.com. Opting out of certain communications may affect our ability to provide services.

23. Artificial Intelligence, Automation, Recordings, and Technology Tools

NuuVim, Bask, Beluga, healthcare practitioners, or service providers may use technology tools to support intake, documentation, communication, quality assurance, customer support, care coordination, or operational workflows.

These tools may include automated systems, clinical decision support tools, documentation tools, transcription tools, quality review tools, or artificial intelligence-enabled tools, where permitted by law and applicable policy.

Technology tools are intended to support, not replace, the professional judgment of licensed healthcare practitioners. Clinical decisions are made by licensed healthcare practitioners.

Audio, video, or call recordings may be used only where permitted by law and applicable policy. If a live visit or call is recorded, you will be notified where required by law.

24. Medical Records

Information you provide through the telehealth platform and information generated by your healthcare practitioner may become part of your medical record.

You may have the right to access, receive, amend, or request transmission of your medical records in accordance with applicable law.

To request medical records, contact:

admin@belugahealth.com

Your healthcare practitioner or medical group may be able to send records to your primary care provider or another treating provider with your consent where required or permitted by law.

You understand you may withdraw your consent and delete your patient profile at any time by emailing admin@belugahealth.com

25. Relationship With Your Primary Care Provider

NuuVim’s telehealth-supported services are not a replacement for primary care. You should maintain a relationship with a primary care provider and seek routine preventive care, in-person evaluation, and ongoing management of chronic conditions as appropriate.

Your healthcare practitioner may recommend that you consult your primary care provider, obtain laboratory testing, seek specialist care, or pursue in-person care.

With your consent, and where required or permitted by law, your telehealth treatment records may be sent to your primary care provider or other treating healthcare provider.

26. Minors

NuuVim services are intended only for adults unless expressly stated otherwise and permitted by applicable law.

If services are ever made available to minors, a parent or legal guardian must provide consent where required by law, and additional state-specific rules may apply.

27. Advertising and Educational Information

Information on NuuVim’s website, advertisements, social media, emails, SMS messages, and other materials is for general informational and educational purposes and is not medical advice.

Only a licensed healthcare practitioner can determine whether treatment is medically appropriate for you.

Any testimonials, reviews, examples, before-and-after content, or weight-loss references reflect individual experiences and do not guarantee that you will have the same or similar results.

NuuVim does not claim that any compounded medication is FDA-approved. NuuVim does not claim that compounded medications are the same as FDA-approved brand-name medications.

28. State-Specific Disclosures

The following state-specific disclosures may apply depending on your location and the location of your healthcare practitioner. These disclosures are intended to supplement, not replace, any state-specific consent, notice, or disclosure provided by Bask, Beluga, your healthcare practitioner, or the dispensing pharmacy.

Important: State telehealth, prescribing, pharmacy, privacy, billing, and consumer notice requirements change over time. NuuVim, Bask, Beluga, and the applicable healthcare practitioners may update state-specific disclosures as required.

ADDITIONAL STATE-SPECIFIC DISCLOSURES

The following consents apply to patients accessing the Services for the purposes of participating in a telehealth visit within the states listed below, as required by state law:

Alaska: I understand that my primary care provider may obtain a copy of my records of my telehealth encounter.

California Patients: The Open Payments database is a federal tool used to search payments made by drug and device companies to physician and teaching hospitals. It can be found at https://openpaymentsdata.cms.gov.

For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided above. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.

Treatment Records: I understand that If I live in one of the following states, my primary care provider or other treating physician may obtain a copy of my telehealth treatment records with my consent, and Practice may securely send a copy of my telehealth treatment records to my primary care provider or other treating physician.

Connecticut: I understand that my primary care provider may obtain a copy of my records of my telehealth encounter.

Kansas: I understand that if I have a primary care provider or other treating physician, the person providing telemedicine services must send a report to such primary care or other treating physician of the treatment and services rendered to me during the telemedicine encounter within three days of me providing consent to the person providing telemedicine services to send such report.

New Hampshire: I understand that my primary care provider or treating provider may obtain a copy of my records of my telehealth encounter.

New Jersey: I understand I have the right to request a copy of my medical information, and I understand my medical information may be forwarded directly to my primary care provider or health care provider of record, or upon my request, to other health care providers.

Ohio: I understand that my primary care provider may obtain a copy of my records of my telehealth encounter.

South Carolina: I understand that my medical records may be distributed only with my consent and in accordance with applicable laws and regulations to other treating health care practitioners.

Texas: I understand that with my consent my medical records may be sent to my primary care physician within 72 hours after receiving Services.

Billing:

Patients residing in New Jersey, New York, and Rhode Island have the right under each states respective billing laws to request an itemized price list for laboratory results.

Formal Complaints:

California: I have been informed that if I want to register a formal complaint about a provider, I should visit the medical board’s website here, or the physician assistant board’s website here.

Georgia: I have been informed that if I want to register a formal complaint about a provider, I should visit the medical board’s website, here.

Idaho: I have been informed that if I want to register a formal complaint about a provider, I should visit the medical board’s website, here.

Indiana: I have been informed that if I want to register a formal complaint about a provider, I should visit the medical board’s website, here.

Iowa: I have been informed that if I want to register a formal complaint about a provider, I should visit the medical board’s website, here.

Kentucky: I have been informed that if I want to register a formal complaint about a provider, I should visit the medical board’s website, here.

Maine: I have been informed that if I want to register a formal complaint about a provider, I should visit the medical board’s website, here.

New York: I have been informed that to get information regarding your rights and how to report professional misconduct, I should visit here.

Oklahoma: I have been informed that if I want to register a formal complaint about a provider, I should visit the medical board’s website, here; or, the Oklahoma Board of Osteopathic Examiners’ website, here.

Oregon: I have been informed that if I want to register a formal complaint about a provider, I should visit the medical board’s website, here.

Rhode Island: I have been informed that if I want to register a formal complaint about a provider, I should visit the medical board’s website, here.

Texas:

NOTICE CONCERNING COMPLAINTS - Complaints about physicians, as well as other licensees and registrants of the Texas Medical Board, including physician assistants, acupuncturists, and surgical assistants may be reported for investigation at the following address: Texas Medical Board, Attention: Investigations, 333 Guadalupe, Tower 3, Suite 610, P.O. Box 2018, MC-263, Austin, Texas 78768-2018, Assistance in filing a complaint is available by calling the following telephone number: 1-800-201-9353, For more information, please visit our website at www.tmb.state.tx.us.

AVISO SOBRE LAS QUEJAS - Las quejas sobre médicos, asi como sobre otros profesionales acreditados e inscritos del Consejo Médico de Tejas, incluyendo asistentes de médicos, practicantes de acupuntura y asistentes de cirugia, se pueden presentar en la siguiente dirección para ser investigadas: Texas Medical Board, Attention: Investigations, 333 Guadalupe, Tower 3, Suite 610, P.O. Box 2018, MC-263, Austin, Texas 78768-2018, Si necesita ayuda para presentar una queja, llame al: 1-800-201-9353, Para obtener más información, visite nuestro sitio web en www.tmb.state.tx.us.

Vermont: I have been informed that if I want to register a formal complaint about a provider, I should visit the medical board’s website, here; or, the Vermont Board of Osteopathic Examiners’ website, here.

Wyoming: I have been informed that if I want to register a formal complaint about a provider, I should visit the medical board’s website, here.

29. Acknowledgment

By using NuuVim’s services, continuing through the intake process, or accepting any applicable consent, you acknowledge that:

1. You have read and understand these Telehealth & Prescription Medication Disclosures.
2. You understand that NuuVim is not a medical group, pharmacy, or healthcare practitioner.
3. You understand that medical care is provided by licensed healthcare practitioners through the applicable medical group or telehealth platform.
4. You understand that telehealth has risks and limitations.
5. You understand that prescription medication is available only if a licensed healthcare practitioner determines that it is medically appropriate and legally permissible.
6. You understand that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing.
7. You understand that completion of an intake form or payment does not guarantee treatment, a prescription, medication shipment, weight loss, or any specific result.
8. You agree to provide accurate, complete, and current information.
9. You understand that you should seek emergency medical care by calling 911 or going to the nearest emergency room if you believe you are experiencing a medical emergency.